“We know that embryonic stem cells are difficult to culture and to control. … Even people in this field say that if treatment is going to come out of this, it's probably 20 years away.”
Instead of spending money on embryonic stem cell research, “we should put our money where we can get real cures real fast”—with adult stem cells, which already have shown promising preliminary results, Dr. Stevens said. “If we have one path we can go down which is cheaper, less complicated, and gets us to cures quickly, why would we go down another path?”
The order refers to embryonic stem cell research, which is not being applied to rheumatic disorders. DR. TYNDALL